Detalles de la búsqueda
1.
Burden of Atopic Dermatitis in Pediatric Patients: An International Cross-sectional Study.
Br J Dermatol
; 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048385
2.
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Allergy
; 77(7): 2211-2221, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35034364
3.
Development and validation of a caregiver-reported Numeric Rating Scale for measuring worst scratch/itch in patients aged 6 months to younger than 6 years with atopic dermatitis.
J Am Acad Dermatol
; 90(2): 382-385, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778662
4.
Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US.
Int J Clin Pract
; 73(8): e13207, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30011108
5.
Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness.
Community Ment Health J
; 54(6): 725-734, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29285684
6.
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies.
Clin Exp Allergy
; 52(2): 244-249, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092110
7.
Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
CNS Spectr
; 22(2): 220-227, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264739
8.
Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records.
Ann Gen Psychiatry
; 16: 36, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29075309
9.
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6-11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial.
Am J Clin Dermatol
; 24(5): 787-798, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300760
10.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Dermatol Ther (Heidelb)
; 13(9): 2107-2120, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552431
11.
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey).
Dermatol Ther (Heidelb)
; 13(4): 961-980, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922463
12.
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
J Asthma Allergy
; 16: 323-332, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016622
13.
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps.
Clin Transl Immunology
; 12(1): e1433, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721661
14.
Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension-CORRIGENDUM.
CNS Spectr
; 22(4): 373, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463099
15.
Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis.
Clinicoecon Outcomes Res
; 14: 691-697, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36389100
16.
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 12(12): 2839-2850, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269504
17.
Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds.
Laryngoscope
; 132(2): 259-264, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817082
18.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Am J Clin Dermatol
; 23(3): 365-383, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567671
19.
Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
Laryngoscope
; 132(2): 265-271, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850966
20.
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
J Allergy Clin Immunol Pract
; 9(6): 2461-2471.e5, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548517